People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Candesant Biomedical, Inc. | — | Other Health Care | Series B | $44.5M | $455.3M | 2022 |
Michael L. Kane at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael L. Kane on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Karen L. Long | 1 | 1 |
| Brad L. Hauser | 1 | 1 |
| Niquette L. Hunt | 1 | 1 |
| Mary Beth L. Kreissler | 1 | 1 |
| Samara L. Braunstein | 1 | 1 |
| Eileen L. McGuire | 1 | 1 |
| Amy L. Schulman | 1 | 1 |
| Robert L. Grove, Ph.D. | 1 | 1 |
| Michael A. C. Kane, M.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.